These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 407731)

  • 1. Species differences in metabolism of tiaramide hydrochloride, a new anti-inflammatory agent.
    Noguchi H; Okui M; Noda K; Sugiura M; Tanaka Y; Kato R
    Xenobiotica; 1977 Aug; 7(8):505-16. PubMed ID: 407731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary metabolite profile of tiaramide in man and in some animal species.
    Noguchi H; Tada K; Iwasaki K
    Xenobiotica; 1982 Apr; 12(4):211-20. PubMed ID: 7113257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal N-sulphoconjugation of an alicyclic amine (piperazine), identified as a new metabolite of tiaramide in mouse and rat.
    Iwasaki K; Shiraga T; Noda K; Tada K; Noguchi H
    Xenobiotica; 1983 May; 13(5):273-8. PubMed ID: 6636823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of tiaramide and its metabolites by high performance liquid chromatography.
    Naito S; Tanase A; Yoshihara H; Tominaga H
    Pharm Res; 1985 May; 2(3):140-2. PubMed ID: 24272693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of tiaramide in vitro. II. Oxidation of piperazineethanol group in tiaramide by 105 000 g supernatants from monkey and rat liver.
    Noguchi H; Iwasaki K
    Xenobiotica; 1982 Aug; 12(8):499-508. PubMed ID: 6755927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological and teratological studies of 4((5-chloro-2-oxo-3-benzothiazolinyl)acetyl)-1-piperazine ethanol hydrochloride (Tiaramide hydrochloride), an anti-inflammatory drug.
    Watanabe N; Takashima T; Ito N; Fujii T; Miyazaki K
    Arzneimittelforschung; 1973 Apr; 23(4):504-8. PubMed ID: 4197071
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and metabolic fate of tiaramide hydrochloride, a new anti-inflammatory agent, in the rat.
    Noguchi H; Okui M; Noda K; Kato R
    Xenobiotica; 1977 Aug; 7(8):491-503. PubMed ID: 888450
    [No Abstract]   [Full Text] [Related]  

  • 10. The disposition and metabolism of 14C-tiaramide . HCl in man.
    Klunk LJ; Riska PS; Maynard DE
    Drug Metab Dispos; 1982; 10(3):241-5. PubMed ID: 6125356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of amosulalol hydrochloride, a new combined alpha- and beta-adrenoceptor blocking agent, in rats, dogs and monkeys.
    Sasaki H; Kamimura H; Kaniwa H; Kawamura S; Takaichi M; Yokoshima T
    Xenobiotica; 1984 Aug; 14(8):621-31. PubMed ID: 6149657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
    Nonaka K; Tsujioka T; Tougou K; Mukai H
    Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.
    Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T
    Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of fenbufen in several laboratory animals.
    Chiccarelli FS; Eisner HJ; Van Lear GE
    Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of pramiverine in rats, dogs, and monkeys (author's transl)].
    Steiner K; Diekmann HW; Garbe A; Nowak H
    Arzneimittelforschung; 1976 Apr; 26(4b):717-21. PubMed ID: 821494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
    Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
    Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic disposition of Rolziracetam in laboratory animals.
    Black A; Chang T
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):135-43. PubMed ID: 3691579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.